#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA859694	B	Inhibitory activity against pig brain NAD glycohydrolase (NADase) by radiochemical Nicotinamide release assay	Sus scrofa	4		assay format	Scientific Literature
2.	ALA1799589	B	Inhibition of human CD38 using 20 uM 1, N6-etheno NAD+ as substrate by continuous fluorimetric method	Homo sapiens	20		single protein format	Scientific Literature
3.	ALA1799745	B	Competitive inhibition of human CD38 active site under saturating levels of substrate NAD+	Homo sapiens	1		single protein format	Scientific Literature
4.	ALA1799746	B	Competitive inhibition of human CD38 active site using 20 uM NAD+ as substrate	Homo sapiens	1		single protein format	Scientific Literature
5.	ALA1285540	B	Inhibition of human recombinant CD38 expressed in Pichia pastoris by continuous fluorometric method	Homo sapiens	5		assay format	Scientific Literature
6.	ALA3371548	B	Inhibition of human CD38 catalytic domain assessed as reduction in cADPR hydrolysis incubated for 10 mins by fluorimetric cycling assay	Homo sapiens	6		single protein format	Scientific Literature
7.	ALA3371551	A	Drug metabolism assessed as human CD38 catalytic domain-mediated compound hydrolysis by measuring 8-NH2-N9-butyl-IDPR level at 1 mM by RP-HPLC method	Homo sapiens	1		single protein format	Scientific Literature
8.	ALA3371552	A	Drug level assessed as human CD38 catalytic domain-mediated compound formation using 1 mM 8-NH2-N9-butyl-cIDPR by RP-HPLC method	Homo sapiens	1		single protein format	Scientific Literature
9.	ALA3371553	A	Drug metabolism assessed as human CD38 catalytic domain-mediated compound hydrolysis at 1 mM by RP-HPLC method	Homo sapiens	3		single protein format	Scientific Literature
10.	ALA3371554	A	Drug metabolism assessed as human CD38 catalytic domain-mediated compound hydrolysis by measuring time needed for 50% hydrolysis by RP-HPLC method	Homo sapiens	2		single protein format	Scientific Literature
11.	ALA3371555	A	Drug metabolism assessed as human CD38 catalytic domain-mediated compound hydrolysis at 1 mM using 1 ug/mL CD38 by RP-HPLC method	Homo sapiens	2		single protein format	Scientific Literature
12.	ALA3371556	A	Drug metabolism assessed as human CD38 catalytic domain-mediated compound hydrolysis at 1 mM using 4 mg/mL CD38 by RP-HPLC method	Homo sapiens	2		single protein format	Scientific Literature
13.	ALA3423828	B	Inhibition of human CD38 by HPLC analysis	Homo sapiens	29		single protein format	Scientific Literature
14.	ALA3423829	B	Inhibition of human CD38 at 100 uM by HPLC analysis relative to control	Homo sapiens	29		single protein format	Scientific Literature
15.	ALA3428359	B	Inhibition of human CD38 extracellular domain expressed in Pichia pastoris assessed as NAD hydrolysis by colorimetric-based assay	Homo sapiens	84		assay format	Scientific Literature
16.	ALA3428361	B	Inhibition of wild type fully glycosylated human recombinant CD38-catalyzed NAD hydrolysis	Homo sapiens	4		single protein format	Scientific Literature
17.	ALA3607749	B	Inhibition of human CD38 extracellular domain expressed in Pichia pastoris using CHAPS and NAD by colorimetric-based assay	Homo sapiens	71		assay format	Scientific Literature
18.	ALA4222829	B	Inhibition of recombinant human CD38 extracellular domain expressed in Pichia pastoris using NAD as substrate pretreated for 30 mins followed by substrate addition measured after 15 to 45 mins	Homo sapiens	41		assay format	Scientific Literature
19.	ALA5032487	B	Inhibition of His-tagged human CD38 using etheno-NAD as substrate preincubated for 30 mins followed by substrate addition and further incubated for 10 mins by fluorometry analysis	Homo sapiens	7		single protein format	Scientific Literature
20.	ALA5148891	B	Inhibition of human his tagged CD38 using N6-etheno-NAD as substrate by fluorescence microplate reader assay	Homo sapiens	46		single protein format	Scientific Literature